MANKIND PHARMA LIMITED

India's top condom maker may hike prices on war-linked oil surge

Mankind Pharma Ltd (NSE:MANKIND) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

Indian drugmaker Mankind posts strong quarterly profit on demand for chronic therapies

Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India

India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs